1. Home
  2. HTD vs ABCL Comparison

HTD vs ABCL Comparison

Compare HTD & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTD
  • ABCL
  • Stock Information
  • Founded
  • HTD 2004
  • ABCL 2012
  • Country
  • HTD United States
  • ABCL Canada
  • Employees
  • HTD N/A
  • ABCL N/A
  • Industry
  • HTD Finance Companies
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTD Finance
  • ABCL Health Care
  • Exchange
  • HTD Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • HTD 796.0M
  • ABCL 719.0M
  • IPO Year
  • HTD N/A
  • ABCL 2020
  • Fundamental
  • Price
  • HTD $23.49
  • ABCL $2.76
  • Analyst Decision
  • HTD
  • ABCL Buy
  • Analyst Count
  • HTD 0
  • ABCL 3
  • Target Price
  • HTD N/A
  • ABCL $8.50
  • AVG Volume (30 Days)
  • HTD 92.3K
  • ABCL 2.5M
  • Earning Date
  • HTD 01-01-0001
  • ABCL 11-04-2024
  • Dividend Yield
  • HTD 8.59%
  • ABCL N/A
  • EPS Growth
  • HTD N/A
  • ABCL N/A
  • EPS
  • HTD N/A
  • ABCL N/A
  • Revenue
  • HTD N/A
  • ABCL $32,962,000.00
  • Revenue This Year
  • HTD N/A
  • ABCL N/A
  • Revenue Next Year
  • HTD N/A
  • ABCL $38.78
  • P/E Ratio
  • HTD N/A
  • ABCL N/A
  • Revenue Growth
  • HTD N/A
  • ABCL N/A
  • 52 Week Low
  • HTD $16.17
  • ABCL $2.34
  • 52 Week High
  • HTD $22.13
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • HTD 61.65
  • ABCL 50.74
  • Support Level
  • HTD $22.59
  • ABCL $2.61
  • Resistance Level
  • HTD $23.11
  • ABCL $3.18
  • Average True Range (ATR)
  • HTD 0.30
  • ABCL 0.19
  • MACD
  • HTD 0.06
  • ABCL -0.02
  • Stochastic Oscillator
  • HTD 95.61
  • ABCL 38.24

About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, telecommunication services, industrials, healthcare, real estate, consumer discretionary and short-term investments.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: